(Q44725770)
Statements
An optimal dosing schedule for a novel combination antimetabolite, TAS-102, based on its intracellular metabolism and its incorporation into DNA (English)
Tomohiro Emura
Fumio Nakagawa
Akio Fujioka
Hideyuki Ohshimo
Tatsushi Yokogawa
Hiroyuki Okabe
1 February 2004